Glucose-insulin infusion improves cardiac function during fetal tachycardia  by Schmidt, Michael Rahbek et al.
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OBJECTIVES The aim of this work was to study the effects of substrate deficiency and supplementation on
cardiac function during fetal tachycardia.
BACKGROUND Although sustained fetal tachycardia may lead to cardiac failure and intrauterine death,
neonatal tachycardia is generally better tolerated. Fetal myocardial energy production relies
almost solely on glucose as substrate. We hypothesized that increased substrate availability by
glucose-insulin (GI) infusion would improve fetal myocardial responses to tachycardia.
METHODS We used three porcine models: 1) an isolated fetal heart model; 2) an in vivo fetal model; and
3) an in vivo closed-chest neonatal model. Each animal was randomized to control or GI
treatment during tachycardia. In model 1, the controls were perfused with conventional
Krebs-Henseleit solution containing a glucose concentration of 5.5 mmol/l; the GI hearts
received double glucose concentration and added insulin. In models 2 and 3, the GI animals
received insulin in a 20% glucose solution. All hearts were exposed to 90 min of pacing at 250
to 330 beats/min.
RESULTS The isolated fetal hearts in the GI group showed no decline in dP/dtmax during pacing, while
the controls declined. In the in vivo fetal hearts, dP/dtmax remained unchanged in the GI
group and decreased significantly in the control group. Myocardial glycogen content was
higher in the GI group than in controls. Functional indexes remained unchanged among both
neonatal groups despite a higher glycogen content in the GI group.
CONCLUSIONS Glucose-insulin infusion during fetal tachycardia has a beneficial effect on myocardial
metabolism and cardiac function. These observations may have direct clinical relevance to the
management of fetal arrhythmia. (J Am Coll Cardiol 2004;43:445–52) © 2004 by the
American College of Cardiology Foundationb
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although sustained fetal tachycardia may lead to cardiac
ailure, hydrops, and intrauterine death, neonatal tachycar-
ia is generally better tolerated (1,2). Despite early diagnosis
nd transplacental antiarrhythmic drug exposure, fetal
achycardia has been associated with a mortality of up to
0% (1). The reasons for the rapid fetal demise in these
ituations are not completely understood.
Myocardial metabolism in the normal adult heart de-
ends predominantly on fatty acid oxidation. In contrast,
he fetal heart with fewer and less mature mitochondria
as limited oxidative capacity for long chain fatty acids
ut a very high glycolytic capacity (3). Consequently, the
etus tolerates hypoxia relatively well, whereas prolonged
eriods with increased work demand (e.g., during tachy-
ardia) are deleterious. The transition from predominantly
arbohydrate-dependent to fatty-acid-dependent metabo-
ism occurs during the first weeks of life (4–7).
In the fetal heart, glycogen represents an important
nergy source available during stressful events such as
ompromised placental blood flow or tachycardia. Insulin
timulates glycogenesis in the mature heart, but its meta-
From the *Aarhus University Hospital, Skejby Sygehus, Aarhus, Denmark;
Papworth Hospital NHS Trust, Cambridge, Cambridgeshire, United Kingdom;
Great Ormond Street Hospital for Sick Children, London, United Kingdom; and
Toronto Hospital for Sick Children, Toronto, Ontario, Canada. Supported by the
anish Heart Foundation, Aarhus University, and Aarhus University Hospital.
Manuscript received April 22, 2003; revised manuscript received August 4, 2003,mccepted August 18, 2003.olic effect on the fetal heart is poorly described. Further-
ore, insulin has positive inotropic effects (8) independent
f glucose metabolism (9) and has been suggested as a
reatment for heart failure (HF) (10). Whereas insulin is
nown to improve neonatal cardiac function (11), the fetal
eart has previously been considered resistant to insulin (5).
Based on these observations, we hypothesized that 1)
etal tachycardia depletes myocardial glycogen stores, which
ontributes to deteriorating ventricular function; 2) glucose-
nsulin (GI) administration prevents this depletion and
hereby protects cardiac function during fetal tachycardia;
nd finally, 3) clinically relevant levels of tachycardia are
etter tolerated in terms of cardiac metabolism and function
n the neonatal than the fetal heart.
To test these hypotheses, tachycardia-induced changes in
yocardial function and glycogen stores were studied in
etal and neonatal pigs randomized to either GI or control
nfusions.
ETHODS
anish Landrace pigs were used in all experiments. The
tudies conformed to the guidelines of the American Heart
ssociation on animal research. In all substudies, anesthesia
as induced with midazolam (0.5 mg/kg intramuscularly)
nd azaperone (4 mg/kg intramuscularly) followed by eto-
idate (0.5 mg/kg intravascularly). The pigs were intubated
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nesthesia was maintained with isoflourane 1.5% in an
2-NO2 mixture. After completion of the experiments, the
iglet/sow was euthanized with an overdose of pentobarbi-
al.
solated fetal heart model (Langendorff). Three first-
ime late pregnant sows (100  7 of 114 days of gestation,
ge 1 to 2 years, weight 140 to 185 kg) were used. From
hese, 14 fetuses were randomized to either GI or normal
rebs-Henseleit (control). The sows’ electrolytes, glucose,
nd arterial blood gases were checked hourly, and ho-
eostasis was maintained accordingly. Particular attention
as paid to keeping maternal blood glucose 3 to 7 mmol/l
y 5% glucose infusion.
Each fetus was manipulated in utero through a 30-cm
aramedian incision. The fetus was exposed through a 5-cm
terotomy. The fetal heart was excised, mounted via the
orta on the Langendorff system, and perfused with oxy-
enated Krebs-Henseleit solution. Left ventricular (LV)
ressures were recorded continuously with a balloon-tipped
atheter and stored on a personal computer. Left ventricular
P/dtmax and dP/dtmin were used as indexes of systolic and
iastolic performance.
The protocol was followed in all experiments:
) 30-min stabilization on Krebs-Henseleit solution (5.5
mmol/l glucose).
) Randomization to GI or control treatment. If random-
ized to GI, the perfusion was switched to a modified
Krebs-Henseleit solution containing 11 mmol/l glucose
and 10 mU/ml insulin (pharmacologic dose).
) Right atrial (RA) pacing at 250 beats/min (with a Grass
simulator, Grass Telefactor, West Warwick, Rhode
Island) for 90 min. Pressure curves were stored on a
personal computer for later analysis.
) Hearts snap-frozen (within 2 s) in liquid nitrogen and
analyzed for glycogen content.
etal in vivo model. One to four fetuses (weight, 825 
50 g) from each of 12 first-time pregnant sows (gestational
ge, weight, and age as above) were studied. The uterus was
xposed through a paramedian 20- to-30 cm incision, and a
etus was manipulated in utero through the incision while
he remaining fetuses (still in utero) were left intra-
bdominally. Six hearts from random fetuses were removed
mmediately after uterotomy and frozen for analysis to
stablish a reference for myocardial basal glycogen content.
Abbreviations and Acronyms
AV  atrioventricular
GI  glucose-insulin
FFR  force-frequency relationship
HF  heart failure
LV  left ventricle/ventricular
RA  right atrial/atriumor the hemodynamic experiments, each fetus was exteri- prized through a 5-cm uterotomy and placed in a small
pecially designed, heated, saline-filled bath that provided a
ormothermic and hydrated environment. The fetal head
as kept submerged to prevent initiation of spontaneous
reathing. The fetus remained oxygenated and anesthetized
ia the umbilical cord throughout the experiment. During
he experimental protocol, the bath was covered with
olythene wrap to keep the exposed parts of the fetus moist.
he umbilical cord and the exteriorized part of the uterus
ere kept moist with intermittent warm saline rinses.
A sternotomy was performed, and pacing electrodes were
ttached to the RA appendage and to the thoracic wall and
onnected to an external pacemaker. Through an apical stab
ound, a 2.4F high-fidelity pressure catheter (Millar In-
truments, Houston, Texas) was inserted into the LV.
Left ventricular pressure readings were recorded (accord-
ng to the protocol [see the following text]) at 250 Hz and
tored on a personal computer with dedicated software (CD
eycom, Leiden, Netherlands) for later analysis. Left ven-
ricular dP/dtmax was used as an index of systolic function.
iastolic performance was assessed by tau (half time of
ressure in the end-diastolic phase) approximated by a
onoexponential model with variable asymptote (12).
The protocol listed here was followed in each study:
) 5- to 10-min stabilization.
) Baseline pressure was acquired for the unpaced basal rate
and for the paced basal rate (150 beats/min).
) To define the force-frequency relationship (FFR), pac-
ing rate was increased incrementally from 150 to the
occurrence of atrioventricular (AV) block. After 1 min of
stabilization at each step, an LV pressure measurement
was recorded. After completion of the FFR measure-
ment, the fetuses stabilized for 1 min before starting
continuous pacing at 250 beats/min.
) After insertion of an intravenous line in the left foreleg,
the fetuses were randomized to receive GI infusion or
control (no) treatment. The GI fetuses received insulin
in 20% glucose infused at 5 ml/h corresponding to 100
mU/kg/h (physiologic dose).
) Pacing at 250 beats/min for 90 min. Pressures were
recorded at 0, 30, 60, and 90 min.
) Heart excised (within 10 s) and snap-frozen (within 2
s) in liquid nitrogen for analysis of glycogen content, and
the fetuses were weighed.
eonatal model. Eighteen neonatal piglets (age 7  3
ays, weight 1.6  0.4 kg) were used. A custom-made 8
olar 5F conductance catheter (total interelectrode distance
cm) with integrated micromanometer (Millar Instru-
ents) was placed, under fluoroscopic guidance, into the
pex of the LV via the right carotid artery. It was connected
o a signal processing unit (Sigma 5DF, CD Leycom) for
ontinuous LV pressure and volume assessment. A 6F
0-mm balloon catheter (Boston Scientific, Natick, Massa-
husetts) was inserted via the right internal jugular vein and
ositioned at the junction of the inferior vena cava and the
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reload during measurement of LV elastance (Ees). A 5F
hermodilution catheter was positioned into the pulmonary
rtery via the left internal jugular vein (Baxter Healthcare,
eerfield, Illinois) and connected to a dedicated cardiac
utput processing computer (Com2, Baxter Edwards). Fi-
ally, a size 5F bipolar pacing wire was positioned in the RA
ppendage via the right external jugular vein and connected
o an external pacemaker (Medtronic, Minneapolis, Min-
esota). Pressure and volume data were digitized at 1,000
z and stored on a personal computer with custom
oftware.
The following protocol was conducted:
) Baseline pressure-volume (including Ees) measurements
were obtained at unpaced basal rate and paced at 150
beats/min.
) To define the FFR: pacing rate was incremented in steps
of 10 beats/min from 150 beats/min until occurrence of
AV block. After 1-min stabilization at each step, the
pressure traces were stored for dP/dtmax analysis. After
completion of the FFR measurement, the neonates
stabilized for 1 min at 150 beats/min before 90-min
pacing.
) Each animal was then randomized to GI or control
treatment. If randomized to GI, infusion of insulin in
20% glucose at a rate of weight (in kg)*5 ml/h corre-
sponding to 100 mU/kg/h.
) Pacing for 90 min at 25 beats/min higher than the
individual “critical heart rate” (the rate at which maximal
force was developed measured from the FFR). Pressure-
volume data were saved at 0, 30, 60, and 90 min.
) The heart excised (within 30 s) and snap-frozen (within
2 s) for analysis for glycogen content.
etabolic analysis. Glycogen concentrations were ana-
yzed as previously described (13) and expressed in nmol
cid extractable free glycogen/mg wet weight biopsy.
tatistical analysis. Mean changes in peak force (dP/
tmax), contractility (Ees), diastolic performance (tau, dP/
tmin), and glycogen content during the 90 min of pacing
ere compared (control vs. GI) using the Student unpaired
test. Fetal and neonatal FFR data were compared using
tudent t test on summary measures (14). Glycogen content
as related to survival time using linear regression. Values
re described as mean  SD unless otherwise stated.
ESULTS
solated fetal hearts. Total sow anesthesia time was ap-
roximately 5 h. All 14 hearts used (7 in each group)
ompleted the protocol without AV block. Baseline LV
P/dtmax and dP/dtmin (obtained after 30 min of stabiliza-
ion) were similar in both groups.
During 90 min of pacing at 250 beats/min, LV dP/dtmax
ecreased 16.9  4.3% in the control group but increased
.5  12.4% in the GI group (p  0.005) (Figs. 1 and 2).imilarly, LV dP/dtmin increased 17.8  3.8% in controls
ut remained unchanged (0.6  14.9 %) in the GI group (p
0.05) (Figs. 1 and 2). Myocardial glycogen content after
acing was 40.4  11.7 nmol/mg in the control group and
2.4  14.8 nmol/mg in the GI group (NS, p  0.11,
espectively) (Fig. 3). There was no relationship between
rder of, or time from, removal of the fetal heart from the
ow and heart function.
etal in vivo model. The stability of this model was tested
n six fetuses that remained unpaced but thoracotomized
nd placed in the saline bath for 2 h while connected to the
ow via the umbilical cord. They showed no changes in
ystolic or diastolic function during 2 h of monitoring (data
ot shown). Furthermore, the hearts had myocardial glyco-
en contents (37.9  9.9 nmol/mg) similar to those excised
mmediately after uterotomy (see the subsequent text).
In the experimental part of the study, 10 fetuses died
uring preparation due to technical errors during the deli-
ate surgical procedure. Four fetuses died during FFR
easurements and were excluded. Whereas all of 13 fetuses
ncluded completed the initial FFR study, only one fetus in
he control group and two fetuses in the GI group survived
he prolonged pacing protocol. The remaining (5 in each
roup) died during pacing after development of AV block
ollowed by rapid decrease in cardiac function. Mean
urvival time was 60  23 min in controls and 78  9 min
n GI fetuses (NS, p  0.10, respectively). In all cases, fetal
emise (defined as LV pressure 10 mm Hg) occurred a
ew minutes after rapid development of advanced or com-
lete AV block.
FR. Peak LV dP/dtmax occurred at 189  39 beats/min
Fig. 4). The increase in LV dP/dtmax was only 4.3  4.8%
rom baseline (150 beats/min) to peak LV dP/dtmax (Fig. 5).
trioventricular block occurred at 362  81 beats/min.
rolonged pacing. Basal (unpaced) heart rate was 129 
6 beats/min in the control group and 126  19 beats/min
n the GI group (p  NS). Basal LV dP/dtmax was 793 
06 mm Hg/s in the control group and 827  86 mm Hg/s
n the GI group (p  NS). Basal tau was 25.0  3.2 ms in
he control group and 25.0  5.2 ms in the GI group (p 
S).
igure 1. Examples of changes in left ventricular dP/dt in a control (left
anel) and a glucose-insulin-treated (right panel) isolated heart in the
angendorff preparation. There is a progressive fall in dP/dtmax and rise in
P/dtmin throughout the 90-min pacing protocol in the control heart.Left ventricular dP/dtmax declined during up to 90 min of
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table in the GI group (Fig. 5). At 30 min, LV dP/dtmax
ecreased 15.8  21.8% in the control group (n  6) but
ncreased 12.3 20.2% in the GI group (n 7) (p 0.05).
t 60 min, there was a mean decline from 0 min of 24.9 
5.2% in the control group (n  4) compared with an
ncrease of 8.4 22.3% in the GI group (n 7) (p 0.02).
The diastolic performance was significantly impaired in
he control group (Fig. 6). At 30 and 60 min, tau increased
9.1  50.7% and 30.9  13.8% in the control group but
ecreased 5.4  18.6% and 2.4  23.6% in the GI group (p
0.09 and p  0.02).
iochemistry and glycogen. Mean plasma potassium level
t time of death was 3.6  0.4 mmol/l in the control group
nd 3.5  0.5 mmol/l in the GI group (p  NS). Blood
lucose was significantly higher in the GI group (16.3 8.9
s. 4.6  2.2 mmol/l, p  0.01), and mean free myocardial m
ontrol; open bars  GI.
F
glycogen was significantly lower in controls (13.6 11.3 vs.
4.7  12.9 nmol/mg, p  0.005) (Fig. 3). For all animals,
urvival time correlated with myocardial glycogen (r 0.86,
 0.002 [r  0.90, p  0.0005 if the three fetuses
uthanized after 90 min are left out]) (Fig. 6), although two
etuses in the GI group died prematurely despite preserved
yocardial glycogen content (30 nmol/mg).
The fetal hearts removed immediately after uterotomy
ad a mean free glycogen of 42.2  10.3 nmol/mg.
eonatal model. Of the 18 piglets included, six piglets in
ach group completed the whole protocol. Five died due to
ccidental perforation of the heart during manipulation of
atheters, and one died during pacing due to sudden
entricular fibrillation. Basal (unpaced) heart rate was 124
5 beats/min in the control group and 127 9 beats/min in
he GI group (p NS). Basal LV dP/dtmax was 1,242 65igure 2. Box (in quartile range) and whisker (10th to 90th percentile) plot of systolic and diastolic performance of the isolated hearts in the control (left)m Hg/s in the control group and 1,166  183 mm Hg/sigure 3. Comparison of free myocardial content of free glycogen (shown
s nmol/mg wet weight biopsy) in control and glucose-insulin (GI) groups
n the three lines of experiments. *p  0.005; #p  0.01. Solid bars  igure 4. Correlation between survival time and mean free myocardiallycogen content.
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February 4, 2004:445–52 Fetal Tachycardia—Effects of Glucose-Insulinn the GI group (p  NS). Basal tau was 32.8  6.9 ms in
he control group and 36.6  4.8 ms in the GI group (p 
S).
FR. Unlike the fetal hearts, neonatal FFR showed a more
ormal increment and decrement of developed force during
acing. The peak LV dP/dtmax occurred at 229  30
eats/min and increased 13.8  4.3% from baseline (150
eats/min) to the peak LV dP/dtmax (Fig. 4). Atrioventric-
lar block occurred at 312  60 beats/min.
rolonged pacing. The hearts were paced at 262  33
eats/min with no significant difference between the two
roups. There was no significant change in systolic or
iastolic performance during 90-min pacing and no signif-
cant differences in indexes of cardiac function between the
wo groups (Table 1, Fig. 5).
iochemistry and glycogen. At time of heart excision,
otassium was 2.9  0.3 mmol/l in controls and 3.3  0.9
mol/l in the GI group (p NS). Blood glucose was 6.3
.9 mmol/l in controls and 12.3  10.3 mmol/l in the GI
roup (pNS). Mean free myocardial glycogen was 25.8
.8 nmol/mg in the control group and 43.3  5.5 nmol/mg
n the GI group (p  0.01) (Fig. 3).
etal versus neonatal FFR. Basal (unpaced) LV dP/dtmax
as lower in the fetuses (790  90 mm Hg/s) than in the
eonates (1,204  137 mm Hg/s) (p  0.0001). Interest-
ngly, basal tau too was lower in the fetuses (25.0  4.2)
han in the neonates (34.7  5.9) (p  0.0002).
At a baseline rate of 150 beats/min, fetuses had a lower
V dP/dtmax than the neonates (787  73 mm Hg/s vs.
,319  157 mm Hg/s, p  0.001) and lower contractile
eserve with lower heart rate associated with peak LV
P/dtmax (p 0.01) and lower absolute and relative increase
rom baseline to peak LV dP/dtmax (both p  0.001).
ISCUSSION
his study investigated cardiac function during tachycardia
n the porcine fetus and neonate and the effect of glucose
nd insulin on myocardial metabolism and indexes of
ystolic and diastolic function. There were three main
igure 5. Comparison of fetal and neonatal force-frequency relationships
see Results for details). LV  left ventricular.ndings. First, treatment with insulin and glucose improves detal cardiac function during tachycardia. Second, the myo-
ardial metabolic derangement occurring during tachycardia
n the fetus can be prevented by increasing substrate
vailability, and this relates to the improvement in cardiac
unction. Finally, the neonatal heart tolerates both acute and
rolonged clinically relevant tachycardia better than the fetal
eart.
ardiac function. Despite major advances in our under-
tanding of fetal cardiovascular physiology, our knowledge
f fetal myocardial function is incomplete and mostly
elated to studies of flow (i.e., cardiac output). In human
etuses, assessment of cardiac performance has essentially
elied upon information obtained with ultrasound tech-
iques. Thus, to obtain more comprehensive information on
ardiac function in the intrauterine environment, animal
odels are required. These are, for obvious reasons, not only
omplex and difficult to perform but also require the
pplication of accurate measurement techniques adjusted for
se in very small and fragile animals.
Because of the attractive size of the fetal sheep, most fetal
tudies have been performed in ewes with singleton preg-
ancies. In ex utero studies, the porcine model is perhaps
ore often used to study cardiovascular physiology. We
herefore developed a porcine fetal in vivo model taking
dvantage of the multiple fetuses of the pregnant sow.
Previous findings suggest that the fetal heart operates at
ear peak performance with limited compensatory mecha-
isms (15). This is supported by our observations, which
learly show that increasing heart rates result in declining
ardiac function, thus obviating tachycardia as a compensa-
ory response. The FFR curves show that fetal LV dP/dt max
s at a much lower level than in neonates, but, more
mportantly, that LV dP/dt max increases only marginally
uring incremental pacing from 150 beats/min before fall-
ng. Furthermore, pacing at 250 beats/min was associated
ith deterioration in both systolic (dP/dt max) and diastolic
dP/dt min and tau) LV function in both isolated and in vivo
etal hearts. Loading conditions were unchanged in the
solated hearts during tachycardia, suggesting that the dif-
erences are likely to reflect true deterioration in myocardial
ontractility and relaxation.
In contrast to the flat response in the fetal hearts, the
FR curve in neonatal hearts showed a greater incremental
esponse of dP/dt to increasing heart rates with overall
igher absolute values. Indeed, the increase in dP/dtmax
14% vs. 4%, p  0.05) was higher, and the critical heart
ate occurred at higher heart rate, at 120  31 versus 60 
8 (p  0.05) above unpaced heart rate in the neonates and
etuses, respectively.
The increase in inotropic state during the transition from
etal to neonatal life and the positive FFR of the newborn
ave been observed previously (16), but the marked differ-
nce in basal LV dP/dtmax and FFR observed in this study
as striking. Importantly, this maturation appears only to
e beneficial to systolic function, as the neonatal indexes of
iastolic performance were the same as, or inferior to, values
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annot be provided by our study, and are probably multi-
actorial. However, the circulatory shift from fetal to neo-
atal conditions is associated with a rise in preload, which,
igure 6. Individual fetal (in vivo) and neonatal systolic (dP/dtmax) and
lucose-insulin-treated (right panels) animals. Truncated curves illustraten itself, would lead to higher LV dP/dtmax (17), indepen-ent of any direct myocardial inotropic or neurohumoral
ffects. No matter the mechanism, the neonates seem better
dapted to meet the challenges of increased heart rate, and
he myocardial demands associated with it.
lic (tau) function during 90 min of pacing in controls (left panels) and
ature death.diasto
premThe mechanisms responsible for the differences in func-
t
h
s
r
d
i
h
t
a
s
M
e
t
a
s
t
b
s
e
g
i
w
(
o
c
i
c
z
a
s
T
t
t
a
t
s
(
o
t
f
b
h
c
f
a
G
b
a
d
(
d
c
M
A
c
m
e
r
p
e
M
h
c
d
b
w
d
w
i
s
K
a
c
t
o
e
m
p
p
d
d
d
i
c
h
t
d
t
h
P
b
i
a
T
C
d
E
E
T
d
E
E
p
451JACC Vol. 43, No. 3, 2004 Schmidt et al.
February 4, 2004:445–52 Fetal Tachycardia—Effects of Glucose-Insulinional response to prolonged tachycardia seen in the fetal
earts are also likely to be multifactorial. Although one
tudy has described changes in fetal LV function related to
educed preload (15), Ascuitto et al. (18) have shown a
irect relationship between diastolic dysfunction and inhib-
ted glycolysis in pacing-induced tachycardia in the neonatal
eart. This relation is supported by our studies, suggesting
hat, at least in part, both systolic and diastolic dysfunction
re related to depletion of myocardial-dependent energy
tores.
yocardial metabolism. In the mature heart myocytes,
nergy production can occur from the metabolism of mul-
iple substrates, including free fatty acids, glucose, and even
mino acids. In fetal life, glucose is the predominant
ubstrate. Cellular metabolism of glucose takes place
hrough glycolysis (anaerobic) and glucose oxidation (aero-
ic). In the fetal heart, glycolysis predominates (5). The
ubstrate for glycolysis is glucose-6-phosphate derived from
ither glycogen or exogenous glucose. The very high glyco-
en content in fetal myocytes, therefore, represents an
mportant energy source readily available during conditions
ith increased demand such as hypoxia or tachycardia
19,20). Although glycogen depletion has been shown to
ccur in adult hearts during prolonged cardiac stress and to
orrelate to deteriorating cardiac function, the current study
s the first to show this effect with fetal tachycardia.
The transition from fetal to neonatal metabolism is a
omplex process that involves changes in myocardial en-
yme expression and maturation of mitochondrial structure
nd function (21). It results in adjustment to the altered
ubstrate availability and conditions of extrauterine life (21).
he shift in metabolism is also assumed to involve acquisi-
ion of myocardial insulin sensitivity when the glucose
ransporters and the hexokinase change isoform from 1 to 4
nd I to II, respectively. This is predominantly a postnatal
ransition, but studies in rats have shown the presence of
mall amounts of adult isoforms (4 and II) in late gestation
22). Nonetheless, it is clear that, at clinically relevant levels
f tachycardia, rapid depletion of glycogen stores occurs in
he fetal heart, and there is an associated decline in fetal
unction. A similarly relevant tachycardia in the neonates is
etter tolerated both in terms of cellular metabolism and
eart function.
able 1. Relative Change in Systolic and Diastolic Indices of
ardiac Function in Neonatal Pigs
Change 0–90 min in
% (SD)
Control
(n  6)
GI
(n  6) p Value
P/dtmax (mm Hg/s) 11.6 (12.1) 4.0 (13.5) 0.06
SPVR (mm Hg/ml) 15.7 (24.4) 32.7 (41.8) 0.28
a (mm Hg/ml) 17.0 (32.7) 2.8 (18.5) 0.47
au (ms) 18.6 (20.1) 1.9 (10.6) 0.06
P/dtmin (mm Hg/s) 6.0 (21.8) 8.3 (26.8) 0.34
DPVR (mm Hg/ml) 5.1 (17.3) 4.8 (36.8) 0.98
DPVR  end-diastolic pressure-volume relationship; ESPVR  end-systolic
ressure-volume relationship; GI  glucose-insulin.Our results can also be interpreted as demonstrating fetal nardiac sensitivity to insulin. The finding that cardiac
unction in the in vitro control hearts declined in the
bsence of changes in glycogen but remained stable in the
I group suggests that insulin not only improves function
y replenishing the glycogen stores but may also have
dditional effects by stimulating the glycolytic flux or by
irect positive inotropy independent of glucose metabolism
9).
Some of the fetuses that received GI in the in vivo model
ied during prolonged pacing despite preserved high myo-
ardial glycogen content. The reason for this is not clear.
ost fetuses died after sudden development of progressive
V block followed by a dramatic and irreversible decrease in
ardiac function. Although we cannot exclude a direct
yocardial effect, the mode of failure suggests that an
lectrophysiologic event may contribute. Little is known
egarding the metabolism of fetal conductive tissue, but it is
ossible that this specialized myocardium behaves in differ-
nt ways to that of the contractile myocardium.
odel considerations/limitations. The isolated fetal
earts generally were more resistant to the effects of tachy-
ardia than the fetal hearts examined in vivo. This may be
ue to an inherent limitation of the Langendorff model
ecause the hearts are perfused under constant pressure and
ith constant high oxygenation. Similarly, the effect of
enervation is not known.
In the Langendorff model, pharmacologic doses of insulin
ere used to study whether it was at all possible to induce an
nsulin-stimulated effect on fetal cardiac function in a
tress-response setting. Hence, no insulin was added to the
rebs-Henseleit solution in the control group, in order to
void the potential confounding direct effects of insulin on
ontractile function. This study offers no direct evidence of
he beneficial effect of insulin per se, and such proof could
nly be provided by a study of fetal cardiac function during
uinsulinemic hyperglycemia.
The rationale for using physiologic doses in the in vivo
odels was to avoid hypokalemia, and to increase the
otential clinical applicability of the findings. Diastolic
erformance in the isolated heart studies is described by
P/dtmin as this was the immediately available index for
iastolic function. Tau is generally considered a less load-
ependent index of diastolic function (12), but in the
solated heart model, this is of less significance, as loading
onditions are constant. In the in vivo model, we used
igh-fidelity pressure catheters and software that allowed
au calculation.
Clinical cardiac dysfunction develops slowly over hours or
ays in the human fetus with tachycardia. To avoid uncon-
rolled side effects of long periods of maternal anesthesia,
owever, we wanted a model that caused HF more rapidly.
ilot studies indicated that 90 min of pacing at 250
eats/min was a feasible protocol to achieve tachycardia-
nduced HF, and we believe that this stimulus is relevant
nd comparable to the clinical situation, although possibly
ot reflecting all aspects of human fetal tachycardia.
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or many hours. Although pragmatically a fixed rate protocol
ould have been used, our aim was to induce a uniform stress.
hus, the neonatal protocol was derived to adjust to individual
ontractile reserve, and each animal was paced at 25 beats/min
bove the critical heart rate. Although this led to the use of
ifferent pacemaker rates, it resulted in a more homogenous
yocardial response to pacing and less intragroup variation.
linical implications. Fetal supraventricular tachycardia is
ow the most common cause of fetal hydrops (severe HF),
hich may be associated with fetal demise if not appropri-
tely treated. Although the optimal treatment of fetal
achycardia has not been established, the mainstay is trans-
lacental drug therapy. However, the optimal treatment of
etal tachycardia remains to be clarified. Digoxin, flecainide
1), beta-blockers, and calcium antagonists (23) have all
een used. However, because drugs are usually given to the
other and transferred to the fetus by transplacental pas-
age, fetal drug concentrations are unpredictable, particu-
arly in the hydropic fetoplacental unit. This study suggests
hat prenatal cardiac function may be improved by meta-
olic intervention, and although this clearly requires further
nvestigation, our data suggest a possible additional thera-
eutic option. Maternal hyperglycemia (e.g., with gesta-
ional diabetes) is well known to induce fetal hyperinsulin-
sm with increased myocardial glycogen deposition and
econdary hypertrophy. It is interesting to speculate that
mposed maternal hyperglycemia might lead to beneficial
esponses during tachycardia, before direct treatment of the
achycardia with antiarrhythmic agents.
onclusions. Fetal tachycardia is associated with important
ystolic and diastolic dysfunction in association with reduced
yocyte glycogen stores. Glucose-insulin infusion leads to
mproved glycogen stores during tachycardia and obviates this
yocardial dysfunction. These findings may have therapeutic
mplications for the management of human fetal tachycardia
ssociated with myocardial dysfunction.
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